+29.1%
MRNA vs RCAT
+733.0%
-703.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.6% | +1.4% | +0.8% |
| 7D | -8.2% | -5.4% | -2.8% | -7.8% |
| 30D | +125.6% | -24.2% | +149.8% | +130.2% |
| 3M | +197.1% | -25.8% | +222.9% | +202.4% |
| 6M | +148.5% | -44.9% | +193.4% | +156.1% |
| YTD | +363.3% | +1.9% | +361.4% | +352.2% |
| 1Y | +462.0% | -5.2% | +467.2% | +444.1% |
| All | +29.1% | +733.0% | -703.9% | +10.8% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling